Keyword: Vividion Therapeutics

Vividion Therapeutics

Vividion Therapeutics seeks to deploy its synthetic and proteomic chemistry platforms to “dramatically expand” the number of targets that can be approached therapeutically. Its technology identifies previously unknown druggable targets in the human proteome.

FierceBiotech's 2017 Fierce 15

The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the brightest teams, and we want to see the promise that they hold in their hands has a genuine chance of being the Next Big Thing. Here are this year's standouts.